Clinical outcomes and serologic response in solid organ transplant recipients with COVID‐19: A case series from the United States

Author:

Fung Monica1,Chiu Charles Y.123,DeVoe Catherine1,Doernberg Sarah B.1,Schwartz Brian S.1,Langelier Charles14,Henrich Timothy J.15,Yokoe Deborah1,Davis John1,Hays Steven R.6,Chandran Sindhu7,Kukreja Jasleen8,Ng Dianna2,Prostko John9,Taylor Russell9,Reyes Kevin2,Bainbridge Emma1,Bond Allison1,Chin‐Hong Peter1,Babik Jennifer M.1

Affiliation:

1. Division of Infectious Disease Department of Medicine University of California San Francisco San Francisco CaliforniaUSA

2. Department of Laboratory Medicine University of California San Francisco CaliforniaUSA

3. UCSF‐Abbott Viral Diagnostics and Discovery Center San Francisco CaliforniaUSA

4. Chan Zuckerberg Biohub San Francisco CaliforniaUSA

5. Division of Experimental Medicine University of California San Francisco San Francisco CaliforniaUSA

6. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine Department of Medicine University of California San Francisco San Francisco CaliforniaUSA

7. Division of Nephrology Department of Medicine University of California San Francisco San Francisco CaliforniaUSA

8. Division of Adult Cardiothoracic Surgery Department of Surgery University of California San Francisco San Francisco CaliforniaUSA

9. Abbott Laboratories, Inc. Abbott Park Illinois USA

Funder

National Institutes of Health

Abbott Laboratories

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference32 articles.

1. World Health Organization.WHO statement regarding cluster of pneumonia cases in Wuhan China.https://www.who.int/china/news/detail/09‐01‐2020‐who‐statement‐regarding‐cluster‐of‐pneumonia‐cases‐in‐wuhan‐china. Published 2019. Accessed August 4 2020

2. An interactive web-based dashboard to track COVID-19 in real time

3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

5. Clinical Characteristics of Coronavirus Disease 2019 in China

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3